Catalog Technologies is a DNA-based data storage and computing company founded by MIT scientists. The company develops synthetic DNA technology to encode, store, and compute digital data, offering a sustainable alternative to traditional data storage with potential for long-term archival (1,000+ years) and massive parallel computation capabilities.
Catalog (Biotechnology) has been acquired
This company is no longer available on our private secondary market.
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
2016
Employees
11–50
Total Funding
$55.5M
4 rounds
Acquired by Biomemory, which bought Catalog Technologies' DNA printing/reading assets in an asset sale
Asset sale by acquirer suggests wind-down; no further liquidity event expected for Catalog equity holders
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Total raised $55.5M across 4 rounds
Last updated 10-01-2026
| Date | Round | Amount Raised | Valuation | Lead Investors |
|---|---|---|---|---|
| Sep 30, 2021 | Series B TechCrunch | $35M | — | Hanwha Impact |
| Sep 8, 2020 | Series A Press release | $10M | — | Horizons Ventures |
| Oct 2018 | Seed (early) | $1.5M | — | Not disclosed |
Hyunjun Park
Co-founder & CEO
Nathaniel Roquet
Co-founder & Chief Technology Officer
Competitor list is illustrative and may be incomplete, stale, or erroneous.
Biomemory
French DNA data storage company that acquired Catalog Technologies; specializes in enzymatic DNA synthesis for secure data storage.
DNA Script
DNA synthesis company developing programmable DNA printers for synthetic biology and data storage applications.
Intrexon (now Precigen)
Synthetic biology company working on DNA-based solutions for agriculture, healthcare, and data storage.
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.